Company Monitoring Page for Epizyme

latest headlines for company on cafepharma

Epizyme: The Ugly Duckling Of The 2014 Biotech Rally?
Seeking Alpha
Fri, 01/2/15 - 10:30 am
Tags:
Epizyme
Epizyme Gains on Positive Phase I Data on EPZ-6438
Yahoo/Zacks
Sat, 11/22/14 - 10:27 am
Tags:
Epizyme, EPZ-6438, non-Hodgkin B-cell lymphoma
Biotech Stocks Get Turbo Boost From Idenix Deal
Seeking Alpha
Thu, 06/12/14 - 09:33 am
Tags:
M&A, Merck, Idenix, Achillion, Agios, Alkermes, Celldex Therapeutics, Vertex, Seattle Genetics, Epizyme
Cellceutix Is Significantly Undervalued Considering The Value Of Brilacidin
Seeking Alpha
Tue, 01/28/14 - 11:19 am
Tags:
Cellceutix, Brilacidin, Kevetrin, Cubist Pharmaceuticals, Epizyme, Geron
The Best- And Worst-Performing Biotech Stocks,Jan. 3 to Jan. 10
Forbes
Sat, 01/11/14 - 10:13 am
Tags:
Neurocrine, Intercept Pharma, Epizyme, Sangamo BioSciences, OncoMed, Zogenix, Macrogenics, Intrexon, Pharmacyclics, Galena Biopharma
Valeant Dreams Big; Cancer Drug News Lifts Pharmacyclics
Yahoo/Investors Business Daily
Wed, 01/8/14 - 08:05 am
Tags:
Valeant Pharmaceuticals, Pharmacyclics, Imbruvica, Celgene, EPZ-5676, Epizyme
Keep an Eye on Pacific Biosciences, Epizyme, and Merrimack Today
Motley Fool
Fri, 11/22/13 - 10:21 am
Tags:
Pacific Biosciences, Epizyme, Merrimack Pharmaceuticals
This Week in Biotech
Motley Fool
Sat, 11/16/13 - 01:23 pm
Tags:
Vanda, Cadence Pharmaceuticals, Immunogen, Novartis, Pharmacyclics, JNJ, Epizyme, Sarepta Therapeutics, GSK
Epizyme: The Promise Of Personalized Cancer Therapy
Seeking Alpha
Mon, 09/16/13 - 11:03 am
Tags:
Epizyme, personalized medicine, GSK, cancer, Eisai, epigenetics, Celgene
A Time to Test Biotechs' Strength
The Street
Sun, 08/25/13 - 11:31 am
Tags:
Bluebird Bio, Epizyme, Intrexon, NanoString Technologies, LipoScience, Aratana, Heat Biologics, ONYX Pharmaceuticals, Amgen
Epizyme receives ophran drug designation for EPZ-5676
Yahoo/Fly on the Wall
Fri, 08/16/13 - 10:09 am
Tags:
Epizyme, orphan drugs, EPZ-5676
The Best- And Worst-Performing Biotech Stocks July 19 To July 26
Forbes
Mon, 07/29/13 - 12:27 pm
Tags:
TearLab, Array Biopharma, Furiex Pharmaceuticals, InterMune, Prosensa, Boston Scientific, Orexigen, Momenta, Ironwood, INSYS Therapeutics, Sequenom, OncoMed, Abraxis, Sarepta, Epizyme, Tesaro, Synta Pharmaceuticals, Bluebird Bio, Exelixis, Lexicon Pharmaceuticals, Intercept Pharma, GTx
The Best- And Worst-Performing Biotech Stocks July 5 To July 12
Forbes
Mon, 07/15/13 - 11:21 am
Tags:
Vivus, Trius Therapeutics, Prosensa, Pharmacyclics, NxStage Medical, Natus Medical, MiMedx, Merrimack Pharmaceuticals, Intuitive Surgical, InterMune, GTx, Fluidigm, Epizyme, Celldex, Astex, Analogic, Amarin, Alnylam, Alexion, AcelRx
Epizyme hits the biotech IPO queue with rapid R&D plan for cancer drugs
Fierce Biotech
Thu, 04/18/13 - 07:01 pm
Tags:
Epizyme, IPOs, R&D, cancer
Epizyme grabs $4M from partner GlaxoSmithKline
Bizjournals.com
Fri, 10/14/11 - 11:24 am
Tags:
GSK, Epizyme, small molecule drugs
FierceBiotech's 2011 Fierce 15 Biotech Companies
Fierce Biotech
Wed, 09/7/11 - 11:28 am
Tags:
Blueprint Medicines, Cerulean, Cerenis Therapeutics, Epizyme, Forma Therapeutics, Intrexon, Merrimack Pharmaceuticals, f-star, Pfenex, Pearl Therapeutics, Reata, Selecta, Rib-X Pharmaceuticals, Tesaro, Theraclone
Epizyme snags $206M epigenetics deal with Eisai
Fierce Biotech
Thu, 03/10/11 - 12:03 pm
Tags:
Eisai, Epizyme, epigenetics
Life Sciences Deal Flows Boost Positive Mood at JPMorgan Healthcare Conference
Seeking Alpha
Sun, 01/16/11 - 11:43 am
Tags:
life sciences, GSK, Epizyme, BioTie Therapies, Synosia Therapeutics, NextWave Pharmaceuticals, Rib-X Pharmaceuticals, DuPont, Danisco
Epizyme, Glaxo sign deal worth up to $650M
Bizjournals.com
Mon, 01/10/11 - 07:27 pm
Tags:
Epizyme, GSK, personalized medicine

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.